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Maternal hypothyroidism in its overt form affects skeletal development of  the offspring, 
but these data are not available for the subclinical form which is becoming very frequent 
among pregnant women. We hypothesized that the subclinical form of  hypothyroidism 
in rat dams, infl uences the process of  offspring endochondral ossifi cation affecting 
proliferation and differentiation of  chondrocytes, osteoclasts and osteoblasts in pups. 
Seven-day-old male pups (n=18) derived from control dams and dams treated with a 
low dose (1.5 mg/L) or high dose (150 mg/L) of  propylthiouracil in drinking water 
during pregnancy and lactation were used. Histomorphometric analysis of  pups’ tibia 
proximal growth plate, expression of  mRNA, immunohistochemical and histochemical 
visualization of  extracellular matrix components was performed. The length of  the tibia 
was reduced in hypothyroid pups. Secretion of  type 2 and 10 collagens in the subclinical 
and overt form were lower while the amount of  glycosaminoglycans was higher when 
compared with controls. Down-regulated tartrate resistant acid phosphatase mRNA 
indicated altered osteoclasts function while lower expression of  dentin matrix acid 
protein–1 mRNA and reduced synthesis of  type 1 collagen accentuated a compromised 
bone formation in the overt form of  hypothyroidism. The subclinical form of  maternal 
hypothyroidism had a negative effect on the differentiation of  hypertrophic chondrocytes 
and calcifi ed cartilage removal in 7-day-old pups. In addition, overt hypothyroidism 
had a negative effect on the proliferation of  chondrocytes and deposition of  osteoid. 
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Both forms of  hypothyroidism resulted in a decrease of  tibia length due to changes in 
growth plate formation.
Key words: type 1, 2 and 10 collagens, TRAP, DMP-1, hypertrophic chondrocytes, 
offspring hypothyroidism 
INTRODUCTION
Spatial and temporal regulation of  proliferation, differentiation and maturation of  
fetal cells, tissues and organs is largely governed by the mothers’ thyroid hormones 
(TH) during whole pregnancy [1]. The most severe and irreversible changes are seen 
on developing neural tissues and thus, the overt and subclinical form of  maternal 
hypothyroidism are primary associated with intellectual and neurological problems 
of  the offspring [2-4]. With increasing awareness that subclinical hypothyroidism is 
common among pregnant women [5], new investigations are prompted to defi ne more 
subtle changes on tissues other than neural. Low birth weight is frequently reported 
as outcome of  both subclinical and overt form of  maternal hypothyroidism [6,7]. 
Although it is clear that the overt form of  maternal hypothyroidism alters ossifi cation 
in offspring [8] and infl uences the size of  the fetal skeleton [9-11], all the consequences 
of  subclinical form of  maternal hypothyroidism on offspring bone formation are not 
described yet. 
The developmental stage of  rat pups during the suckling phase corresponds to the last 
trimester of  human pregnancy and is marked with immaturity of  TH/TSH axis in both 
species [12]. Thus, investigating effects of  maternal hypothyroidism in a rat offspring 
appropriately mimics and replaces the need to investigate prenatal hypothyroidism 
in human neonates. Commonly used model for hypothyroidism investigation in 
laboratory rodents, is the application of  6-n-propyl-2-thiouracil (PTU) [13]. In the 
thyroid gland PTU reduces TH synthesis while in the peripheral tissues interferes with 
T3 binding to nuclear thyroid hormone receptors and also blocks conversion of  T4 to 
T3 [14]. It is known that a very low dose of  PTU is used for successful modeling of  
the subclinical form of  hypothyroidism [15-17] and the high dose to induce the overt 
form of  maternal hypothyroidism [18]. The comparative approach using both PTU 
doses could be helpful when subtle changes in cartilage and bone should be evaluated 
and interpreted.
The objective of  this study was to investigate effects of  subclinical and overt forms 
of  maternal hypothyroidism on proximal epiphyseal growth plate of  7-day-old pups, 
at the beginning of  growth spurt. Specifi c aims were: 1) to measure the length of  the 
tibia and to describe the histological appearance of  its proximal growth plate; 2) to 
test gene expression for type 2 and type 10 collagen in hypertrophic chondrocytes and 
to analyze the surrounding extracellular matrix (ECM) for the presence of  both types 
of  collagens and glycosaminoglycans; 3) to test gene expression for tartrate resistant 
acid phosphatase (TRAP) in osteoclasts and DMP-1 in osteoblasts, TRAP activity in 
lysosomes of  osteoclasts, type 1 collagen protein expression in osteoblasts and ECM 
and to describe morphological changes in the trabeculae forming the ossifi cation zone.
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MATERIALS AND METHODS
Animals
Eighteen 10-week-old female Albino Oxford rats (weighting 140-160g) obtained from 
the Department of  Laboratory and Experimental Care and Use of  Animals Unit of  
the Institute of  Medical Research, Military Medical Academy (Belgrade, Serbia) and 
eighteen of  their male offspring were used in the experiment. The animals were kept 
under a photoperiodic cycle of  12 h light / 12 h dark in an air-conditioned facility. 
The mean temperature was 21 ± 0.5ºC and the relative humidity 40 ± 7%. Pelleted rat 
feed (PA 20, Veterinary Institute Subotica, Serbia) and drinking water were available 
ad libitum.
Animal handling and treatment were performed with the approval of  the Ethical 
Committee of  the Faculty of  Veterinary Medicine University of  Belgrade (number 
01-20/6), and Ministry of  Agriculture, Forestry and Water Management, Veterinary 
Directorate approval (number 323-07-00364/2017-05/8) and according to the Serbian 
Animal Welfare Protection Law and Directive 2010/63/EU. The procedures with rats 
are described according to the ARRIVE guidelines [19]. In concern with 3R practice, 
organs from pups of  both sexes that were not investigated in this paper were preserved 
for future investigation on maternal hypothyroidism. Also, female pups were used 
for studying investigating effects of  maternal hypothyroidism on ovary development 
[16,17].
Animal model
The fi rst step in our experimental design was to induce subclinical and overt form of  
hypothyroidism in pregnant dams using low (1.5 mg/L) and high (150 mg/L) dose of  
PTU (Sigma Chemical Co., St. Louis, MO, USA) dissolved in drinking water. PTU was 
available ad libitum from day zero of  dams’ pregnancy until the end of  the fi rst week 
post-partum. Gestation day zero was considered as the day after mating characterized 
with the presence of  the vaginal plug. Pregnant females were randomly divided into 
three groups – control (C), low dose (H-1) and high dose PTU (H-2). Each group 
consisted of  six animals. 
Experimental procedure
Seven days after birth, six male pups of  dams from each group were euthanized using 
cervical dislocation and their body weights were recorded. Dams were euthanized at 
the same time point by using 100 mg/kg body weight Euthasol Euthanasia Solution 
(Produlab Pharma Production B.V. Raamsdonksveer, Netherlands). Blood samples 
from dams and pups were collected during the euthanasia protocol in polypropylene 
tubes with heparin (32 U/tube). After separation (1500 g, 10 min), plasma samples 
were stored at -20ºC for up to 2 months before further analyses were done. 
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Tissue collection and processing
After euthanasia thyroid glands were removed from the dams, and the thyroid glands 
and tibiae were removed from the pups. Tibiae were measured with a sliding mechanical 
caliper (accuracy 10 μm). Fixation, paraffi n embedding of  all tissues, deparaffi nization, 
rehydration and staining were done by routine laboratory procedures. After fi xation, 
tibiae were decalcifi ed in 10% EDTA for 10 days. Every fi fth 5-μm-thick section 
of  thyroid glands and tibiae was cut on Superfrost Plus Slides (Menzel-Glaser, 
Saarbruckener, Germany). 
Hematoxylin/eozin (Merck Millipore, Darmstadt, Germany) was used for routine 
morphometry and stereology. Alcian blue (SERVA Electrophoresis GmbH, Heidelberg, 
Germany) for visualization of  glycosaminoglycans and Masson-Goldner trichrome 
(Merck Millipore, Darmstadt, Germany) for visualization of  calcifi ed cartilage and 
bone matrix. Activity in TRAP in osteoclast lysosomes was assessed with leukocyte 
acid phosphatase kit according to the manufacturer’s protocol (Sigma-Aldrich, Poole, 
UK).
Thyroid status assessment 
Thyroid status of  dams was assessed through the determination of  TH concentration 
in plasma and calculation of  the thyroid activation index (Ia) which indirectly 
demonstrated the activity of  TSH. Higher Ia values stand for higher blood TSH levels 
and reversely [20]. The form of  hypothyroidism was defi ned as following: 1) dams were 
considered to have the subclinical form of  hypothyroidism if  their TH concentration 
was not changed, while Ia was higher compared with control animals [16,17] and 2) 
dams were considered to have an overt form of  hypothyroidism if  TH concentration 
was lower, and Ia higher compared with control animals. Thyroid gland stereology and 
Ia were assessed as described previously [16,20]. Briefl y, thyroid glands were analyzed 
using a multipurpose stereological grid M42 (42 testing points in a testing area equal 
to 36.36 d2). The volume density (Vv) of  different thyroid compartments, interstitium 
(Vvi), epithelial tissue (Vve) and colloid (Vvc) were determined. The Ia of  thyroid glands 
was calculated: Ia = Vve/Vvc[20].
Radioimmunoassay for T3 and T4
Triiodothyronine (T3) and thyroxine (T4) concentrations in blood plasma of  dams 
and pups were determined using commercial radioimmunoassay kits (INEP, Zemun, 
Serbia). 
Histomorphometry
Histomorphometric analyses were done on serial sections obtained from medial third 
part of  pups’ tibiae parallel to longitudinal axis. On each section, measurements were 
performed choosing the middle part of  the proximal tibial growth plate. 
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Sections were examined using a microscope equipped with a digital camera and 
adequate software (Olympus CX31 with UC50 Soft Imaging Solutions camera and 
SensEntry 1.13 software, Münster, Germany) by two observers who were blinded 
for the group assignment. The height measurements: the proliferative zone (PZ) and 
hypertrophic zone (HZ) height were measured parallel to the chondrocyte columns. 
The border between PZ and HZ was defi ned by the presence of  the fi rst hypertrophic 
chondrocytes (height ≥10 µm) [21]. The growth plate height was determined as the 
sum of  the PZ and HZ. The resting zone (RZ) was not included in the measurements 
as the uneven development of  the secondary ossifi cation centre (SOC) in the control, 
H-1 and H-2 pups would introduce a large spurious variation between groups. The 
number of  hypertrophic chondrocytes was determined per 1 mm2 of  tissue area 
(objective X40) in HZ. The terminal hypertrophic chondrocytes were defi ned as the 
last ones in the lacunae that were not invaded by metaphyseal blood vessels and their 
average height was obtained after 250 measurements per tibia.
To defi ne the characteristics of  the newly formed trabeculae in the ossifi cation 
zone (OZ), histomorphometric analysis was performed on 10 serial sections of  the 
tibia stained with Masson-Goldner. The complete trabecular volume (TV), calcifi ed 
cartilage volume (CCV) and bone tissue volume (BTV) was calculated as the number 
of  pixels representing the corresponding tissue area divided by the number of  the 
pixel representing the total tissue area [22]. These measurements were made using 
Photoshop (Adobe, San Jose, CA).
TRAP positive area was measured just below the last hypertrophic chondrocyte in 
the ossifi cation zone (OZ) of  the proximal tibial epiphysis. Alcian blue staining for 
quantifi cation of  glycosaminoglycan components of  the extracellular matrix was 
performed according to the protocol described by Ribeiro et al. [23]. Examined 
areas (pixels) on histological sections were measured using Image J software (Media 
Cybernetics Manufacturing, Rockvill, MD).
Immunohistochemistry
Immunohistochemistry (IHC) on paraffi n embedded tissue sections was used to 
determine the presence of  type 1, 2 and 10 collagens. Antigen retrieval was achieved 
by Trypsin Enzymatic Antigen Retrieval Solution (ab970, 1:3 dilution; Abcam, 
Cambridge, UK) at 37ºC and blocked with 3%H2O2. Slides were washed two times 
in PBS and incubated with primary antibodies (Table 1) diluted in IHC Diluent 
(Novocastra, Leica biosystems, Newcastle, UK) overnight at 4°C. For negative 
controls, primary antibodies were omitted. After four washes, the secondary antibody 
was used (EnVision FLEX/HRP, RTU, Dako, Santa Clara, CA, USA). For visualization 
Liquid DAB+ Substrate Chromogen System (Dako, Carpinteria, CA, USA) was used, 
according to the manufacture’s protocol. Counterstaining was carried out with Mayer’s 
haematoxylin and slides were mounted with DPX (Sigma-Aldrich, Poole, UK). The 
immunopositive areas in pixels were determined using Image J software.
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Table 1. Primary antibodies used for immunohistochemistry
Antibodies Manufacturer Dilution
Anti-Collagen I antibody ab34710 Abcam, Cambridge, UK 1:500
Anti-Collagen II antibody ab34712 Abcam, Cambridge, UK 1:200
Anti-Collagen X antibody ab58632 Abcam, Cambridge, UK 1:300
In Situ Hybridization
Serial 5-μm-thick sections from paraffi n-embedded tissues were processed for in situ 
hybridization (ISH) as previously described [24]. Riboprobes were generated from 
PCR amplifi cation of  cDNA by using specifi c primer fl anked by T7 and T3 promoters 
(Table 2.). Antisense and sense digoxigenin-labeled RNA probes were prepared by 
in vitro transcription from a T7 or a T3 promoter (DIG RNA labeling kit, Roche). 
Deparaffi nized sections were treated with 20 μg/ml proteinase K for 10 min at 37°C 
and incubated with 1 μg/ml labelled probe overnight at 60°C. Labeled cells were 
visualized using a DIG nucleic acid detection kit (Roche Applied Science). Sections 
were mounted in aqueous solution (Mowiol®) and scanned using a Hamamatsu 
NanoZoomer HT digital scanner. The number of  osteoblasts/osteocytes expressing 
mRNA for DMP-1 in OZ was determined per 1 mm2 of  tissue area (objective X40).
Table 2. Sequences of  primer pairs, gene bank accession numbers used for generation 
riboprobes and size of  PCR products
Gene GeneBank N° Forward T3 primer Reverse T7 primer
Amplicon size 
(b p)
Col 2a1 NM_031163
5’–GAGAATTAACCC
TCACTAAAGGGTCT
CCTGCCTCCTCCTG
CTC–3’
5’–GAGTAATACG
ACTCACTATAGG
GCTCCATCTCTG
CCACGGGGT–3’
584
Col 10a1 NM_009925
5’–GAGAATTAACCC
TCACTAAAGGGCGG
GTCTGCCTGGATCC
CCT–3’
5’–GAGTAATACG
ACTCACTATAGGG
GCTATGCCAGC
TGGGCCTGG–3’
442
ACP5 NM_001102404
5’–GAGAATTAACCC
TCACTAAAGGGCAG
CTCAGTTGGGTAGC
ACA–3’
5’–GAGTAATACG
ACTCACTATAGG
GACGGTTCTGGC
GATCTCTT–3’
223
DMP-1 NM_016779
5’–GAGAATTAACCC
TCACTAAAGGGAGC
AACAGCAGGGAAA
CC–3’
5’–GAGTAATACG
ACTCACTATAGG
GGCAAAACTGAG
CCTGAAGCAC–3’
1074
Col2a1 – type 2 collagen; Col10a1 – type 10 collagen; ACP5 – tartrate resistant acid phosphatase (TRAP); 
DMP-1 – dentin matrix acid protein–1
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Statistical analysis
Depending on the values of  coeffi cients of  variation (cv), an appropriate method 
was chosen to test the difference between the groups. For homogenous datasets 
(cv<30%) the groups were compared using one-way ANOVA followed by Tukey´s 
multiple comparison test, and for heterogeneous datasets (cv >30%) the groups were 
compared using Kruskal–Wallis ANOVA followed by Dunn’s multiple comparison 
test. Signifi cant difference was estimated at p<0.05, p<0.01, p<0.001 and p<0.0001 
signifi cance levels. Numerical data for homogenous datasets are presented as mean ± 
standard deviation (Mean ± SD) and for heterogeneous datasets as median values with 
corresponding interquartile range (IQR). Statistical analysis of  the results obtained in 
the experiment was carried out using statistical software GraphPad Prism version 6 
(GraphPad, San Diego, CA, USA).
RESULTS
Thyroid status of mothers and pups
In H-1 dams, duration of  pregnancy was not changed (21.8 ± 0.45 days) and in H-2 
dams was prolonged (23 ± 0.71 days, p<0.01) compared with controls (21.40 ± 0.55). 
Litter size was smaller in H-2 dams when compared to H-1 or control ones (C: 9±1.73; 
H-1: 8.8±1.92; H-2: 5.4±1.52; C:H-2 p<0.05). Nesting behavior was preserved in both 
groups of  PTU treated dams. In H-2 dams a rough hair coat was noticed during 
the second week of  pregnancy until euthanasia. Histologically, the thyroid gland of  
dams in both PTU treated groups was characterized by high columnar epithelium and 
low colloid volume (Figure 1A, B, C). As a consequence, Ia of  the thyroid gland was 
signifi cantly increased in both, H-1 and H-2 dams (D). Concentration of  T3 and T4 
was signifi cantly lower only in H-2 dams (Figure 1E, F). 
Seven-day old pups from H-1 and H-2 dams were viable and with normal behavior 
regarding the suckling refl ex and color of  the skin. Body weight was lower in H-1 and 
even lower in H-2 pups when compared with controls (Figure 1G). Stereology of  the 
thyroid gland matched the one seen in dams of  the corresponding group (Figure 1H, 
I, J). In H-1 and H-2 pups, Ia was higher (Figure 1K), while concentrations of  T3 and 
T4 were signifi cantly lower only in H-2 pups (Figure 1L, M).
Morphometry of the tibia and its proximal epiphyseal growth plate
Tibiae were 12.18% shorter in H-1 and 18.11% shorter in H-2 pups compared with 
controls (Figure 2A). SOC of  proximal tibia epiphysis were clearly formed in the 
control, poorly formed in H-1and not present in H-2 pups (Figure 2B, C, D).The height 
of  PZ and HZ differed between groups (Figure 2B, C, D, E). PZ was signifi cantly 
lower only in H-2 pups, while HZ was lower in both, H-1 and H-2 pups (Figure 
2E). Also, the number of  the hypertrophic chondrocytes per mm2 was not changed in 
H-1, while it was signifi cantly higher in H-2 pups (Figure 2F). The height of  terminal 
hypertrophic chondrocytes in H-1 and H-2 pups was signifi cantly lower compared 
with controls (Figure 2G).
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Figure 1. Thyroid status of  dams and their 7-day-old pups from the control group and 6-n-propyl-2-
thyouracil (PTU) treated groups and pups body weight: Thyroid gland histology of  control dams (n=6, 
C) (A) and dams treated with low dose PTU (n=6, H-1) (B) and high dose PTU (n=6, H-2) (C) seven 
days after delivery. Note the high columnar follicular epithelium and low colloid volume in H-1 and H-2 
dams (A, B, C) ( haematoxylin/eosin, bar: 20 µm). Activation index (Ia) (D) and concentration of  T3 (E), 
T4 (F) in control, H-1 and H-2 dams. Body weight (g) was lower in pups from dams treated with the 
low PTU dose (n=6, H-1) and high PTU dose (n=6, H-2) as compared with control pups (n=6, C) (G). 
Note the thyroid gland follicles in control pups (H) and a decrease in colloid and high columnar epithelial 
cells in follicles of  H-1 (I) and H-2 (J) pups (haematoxylin/eosin, bar: 20 µm). Ia (K) and concentration 
of  T3 (L), T4 (M) in control, H-1 and H-2 pups. Boxes indicate the lower to upper quartile (25th-75th 
percentile) and median value. Whiskers extend to minimum and maximum values (*p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001).
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The type 2 collagen, type 10 collagen and Alcian blue staining
in proliferative and hypertrophic zones
The type 2 collagen mRNA expression was weak in PZ and HZ chondrocytes of  
control pups, while it was strong in the chondrocytes of  H-1 and H-2 pups (Figure 
3A, B, C). IHC showed that the amount of  type 2 collagen in PZ and HZ ECM was 
lower in H-1 pups when compared with controls and also, it was lower in H-2 pups 
when compared with H-1 pups (Figure 3D, E, F G). Inversely, the area stained with 
Alcian blue was higher in H-1 pups when compared with controls and higher in H-2 
pups when compared with C and H-1 pups (Figure 4H, I, J K).
Figure 2. Length of  tibia, representative photomicrographs of  longitudinal section (medial third part) 
and morphometry of  proximal tibial epiphysis growth plate in 7-day-old control pups (n=6, C) and in 
pups from dams treated with low PTU dose (n=6, H-1) and high PTU dose (n=6, H-2): Tibia is reduced 
in length in H-1 and H-2 pups as compared with control pups (A). Secondary ossifi cation centre (SOC) 
(arrow) of  proximal tibial epiphysis is well developed in control pups (B), less developed in H-1 (C) and 
undeveloped in H-2 pups (D) (haematoxylin/eosin, bar: 250 µm). Proliferation zone (PZ), hypertrophic 
zone (HZ) and ossifi cation zone (OZ) are well distinguished in all three groups of  pups (B, C, D). Height 
of  PZ is lower in H-2 pups, and height of  HZ and PZ+HZ is lower in H-1 and H-2 pups as compared 
with control pups (E). Number (No) of  hypertrophic chondrocytes (HyC) per mm2 is higher in H-2 pups 
(F) and terminal hypertrophic chondrocytes height (THyC) is lower in H-1 and H-2 pups (G). (*p<0.05, 
**p<0.01, ****p<0.0001).
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The type 10 collagen mRNA expression was strong in HZ chondrocytes of  control 
pups, and it was weak in chondrocytes of  H-1 and H-2 pups (Figure 3L, M, N).  IHC 
showed that the amount of  type 10 collagen in ECM was lower in HZ in H-1 pups 
when compared with controls and also it was lower in H-2 pups when compared with 
H-1 pups (Figure 3O, P, Q, R). 
TRAP, trabecular morphology, type 1 collagen and DMP-1 expression
in the ossifi cation zone
With severity of  hypothyroidism, TRAP mRNA expression in osteoclasts (Figure 4A, 
B, C) and the area covered with lysosomes expressing TRAP activity declined in H-1 
and H-2 pups (Figure 4D, E, F, G).
On Masson-Goldner stained sections it was possible to distinguish green-blue osteoid 
– bone tissue matrix, and colourless calcifi ed cartilage together forming primary bone 
trabeculae (Figure 4H, I, J). In H-1 and H-2 pups they were wider when compared 
with controls (Figure 4H, I, J). Morphometric analysis showed that when compared 
with controls, TV and BTV were not different while CCV was increased in H-1 pups 
(Figure 4K); TV and CCV were increased in H-2 and H-1 pups, while BTV was lower 
only in H-2 pups (Figure 4K).
Osteoblasts in OZ had a well distinguished morphology that was cuboidal on the 
interface of  the newly synthesized bone in control and H-1 pups, while it was spindle 
shaped in H-2 pups (Figure 4L, M, N). IHC showed that amount of  type 1 collagen in 
osteoblasts and ECM was lower in H-1 and H-2 pups when compared to the control 
(Figure 4L, M, N, O). Also, it was lower in H-2 pups when compared with H-1 pups 
(Figure 4M, N, O). The number of  osteoblasts/osteocytes expressing mRNA for 
DMP-1 was decreased in H-1 and H-2 pups when compared with the controls and 
between H-1 and H-2 pups (Figure 5P, Q, R, S).
Figure 3. Representative photomicrographs of  proliferating zone (PZ) and hypertrophic zone (HZ) and 
graphs presenting mean ± standard deviation of  morphometric analysis: In situ hybridization (ISH) for 
type 2 collagen mRNA in PZ and HZ in 7-day-old control pups (n=6, C) (A) and in pups from dams 
treated with low PTU dose (n=6, H-1) (B) and high PTU dose (n=6, H-2) (C) (5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium, bar: 100 µm). Note the weak expression of  mRNA in HZ 
chondrocytes in control pups and very strong expression reaching the chondro-osseous junction in 
H-1 and H-2 pups (C). Immunohistochemical (IHC) detection of  type 2 collagen shows its presence 
in the extracellular matrix (ECM) in control pups (D) and reduction in H-1 (E) and H-2 (F) pups 
(3,3′-diaminobenzidine, counterstain haematoxylin, bar: 20 µm). Area of  HZ with type 2 collagen positive 
signal is lower in H-1 and H-2 pups as compared with control pups (G). Area of  HZ stained with Alcian 
blue was increased in H-1 (I) and H-2 (J) pups as compared with control pups (H, I, J, K) (bar: 20 µm). 
Note the strong expression of  type 10 colla gen mRNA in HZ of  control pups (L), weak expression in 
H-1 (M) and H-2 (N) pups (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium, bar: 50 µm). 
Note that expression of  type 10 collagen in ECM of  HZ is strong in control pups (O), moderate in 
H-1 (P) and weak in H-2 pups (Q) (3,3′-diaminobenzidine, counterstain haematoxylin, bar:20 µm). Area 
with type 10 collagen positive signal is lower in H-1 and H-2 pups as compared with control pups (R). 
(*p<0.05, **p<0.01, ****p<0.0001).
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Figure 4. Representative photomicrographs of  ossifi cation zone and graphs presenting mean and 
standard deviation of  morphometric analysis: In situ hybridization (ISH) for acid phosphatase 5 tartrate 
resistant (TRAP) mRNA in ossifi cation zone in 7-day-old control pups (n=6, C) (A) and in pups from 
dams treated with low PTU dose (n=6, H-1) (B) and high dose PTU (n=6, H-2) (C) (5-bromo-4-chloro-
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3-indolyl phosphate/nitro blue tetrazolium, bar: 50 µm). Note a strong signal next to chondro-osseous 
junction in control pups (A) and weak signal in H-1 (B) and practically absent signal in H-2 pups (C). 
Histochemistry (HC) demonstrates strong purple-violet TRAP activity of  osteoclasts in control pups 
(D), lower signal in H-1 pups (E) and weak signal in H-2 pups (F) (bar: 50 µm). Area stained in purple-
violet was lower in H-1 and H-2 pups as compared with control pups (G). Masson-Goldner staining 
shows green osteoid and colourless calcifi ed cartilage that together form primary trabeculae in the 
ossifi cation zone of  the control (H), H-1 (I) and H-2 (J) pups (bar: 20µm). Morphometric analysis 
shows that trabecular volume (TV) and bone tissue volume (BTV) are not changed in H-1 pups. In H-2 
pups, TV was higher while BTV was lower compared with controls (K). Calcifi ed cartilage volume (CCV) 
was higher in H-1 and H-2 pups compared with controls (K). Immunohistochemical (IHC) detection of  
type 1 collagen shows its presence in osteoblasts/osteocytes and extracellular matrix of  ossifi cation zone 
in control pups (L) and reduction in H-1 (M) and H-2 (N) pups (3,3′-diaminobenzidine, counterstain 
haematoxylin, bar: 20 µm). Fibroblast-like morphology of  osteoblasts could be seen in H-2 pups (N). 
Area with type 1 collagen positive signal is lower in H-1 and H-2 pups as compared with control pups (O). 
ISH for dentin matrix protein-1 (DMP-1) mRNA shows high expression in control pups (P) and lower 
expression in H-1 (Q) and H-2 pups (R) (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium, 
bar: 50µm). Control animals have more DMP-1 positive osteoblasts/osteocytes (OB/OC) (S). (*p<0.05, 
**p<0.01, ****p<0.0001).
DISCUSSION
The main fi ndings of  this study are that the subclinical and overt form of  
hypothyroidism in 7-day-old pups lead to 1) lower body weight and bone length and 2) 
changes in growth plate of  proximal tibia epiphysis that include: a) lower hypertrophic 
chondrocytes size; b) lower amount of  synthesized type 2 and type 10 collagen; c) 
higher HZ glycosaminoglycan content; d) lower TRAP synthesis and activity, lower 
number of  mature osteoblasts (DMP-1 positive cells) and amount of  type 1 collagen 
in osteoblasts and bone ECM. All these changes lead to the formation of  shorter and 
wider primary bone trabeculae. 
In thi s study it was demonstrated that the subclinical and overt form of  maternal 
hypothyroidism lead to the subclinical and overt form of  hypothyroidism in 7-day-
old pups, respectively. Although literature defi nes both forms of  hypothyroidism in 
humans using reference values for TH and TSH [25], in the rat model of  maternal 
hypothyroidism the reference values are not available. Thus, clinical signs in 
conjunction with TH concentration and Ia are used to defi ne the thyroid status of  
dams as well as pups. Main clinical signs in the overt form of  hypothyroidism in dams 
are rough hair coat, prolonged pregnancy and small litter size. These results are in 
accordance with previously described models [6,18]. The main clinical sign in the overt 
form of  hypothyroidism in 7-day-old pups is low body weight. We confi rmed that 
pups with overt hypothyroidism had TH values lower and Ia higher than those with 
the subclinical form of  the disease and the control. Although TSH concentrations 
were not measured, they were estimated indirectly, using the Ia [16,20]. According to 
high Ia in both groups of  hypothyroid pups, we could assume that pups had supra-
physiological levels of  TSH.
Low body weight and the length of  tibia in both groups of  pups might be the 
consequence of  prenatal changes caused by the hypothyroid state of  dams. This is in 
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accordance with low birth weight in human neonates born from subclinical and overt 
hypothyroid mothers [26]. Early infantile rat pups 7-day-old are at the beginning of  
growth spurt [27,28] meaning that all components of  the growth plate are vulnerable 
to hormonal changes. Previously, it was shown that TSH, independently of  TH, acts 
on different components of  growth plate [29]. Thus, it could be considered that 
endochondral ossifi cation in early infantile hypothyroid rat pups is affected with a 
decrease in TH and increase in TSH levels or the balance between these two hormones 
(TH/TSH). 
Subclinical hypothyroid pups maintained nearly normal height of  PZ and nearly equal 
number of  hypertrophic chondrocytes in HZ, while those with the overt form had 
underdeveloped, short PZ and increased number of  hypertrophic chondrocytes in 
HZ. Terminal hypertrophic chondrocytes’ height gradually decreased with the severity 
of  hypothyroidism. Thus, in the overt form of  hypothyroidism, the spatial and 
temporal balance between proliferation and differentiation of  chondrocytes is altered 
leading to accumulation of  chondrocytes that did not acquire adequate hypertrophic 
morphology. In addition, it was previously demonstrated that the TSH receptor was 
expressed on growth plate chondrocytes and that over expression of  TSH in mice 
lead to a decreased height of  the growth plate [30]. These fi ndings point that in the 
overt form of  hypothyroidism, TH/TSH balance does not favor the proliferation of  
chondrocytes, while in the subclinical form the proliferation capacity of  chondrocytes 
is preserved at a nearly normal rate. In both forms differentiation was slowed, but in 
a severity-dependent manner.
This study suggests that PZ chondrocytes contained an increased amount of  type 2 
collagen mRNA in the subclinical and even more in the overt form of  hypothyroidism. 
The amount of  type 2 collagen in ECM was decreased in both treated groups. Similarly, 
the mice model of  hypothyroidism in the early infantile period, has shown that the 
amount of  type 2 collagen is decreased in ECM surrounding epiphyseal chondrocytes 
[8]. Taken together these fi ndings suggest that the defi cit of  TH and possible excess 
of  TSH stimulate the transcription of  type 2 collagen or increase mRNA stability, and 
possibly interfere with post-translation mechanism of  type 2 collagen modifi cation 
and/or its secretion in ECM.
This study also showed that ECM of  HZ in the subclinical and overt form hypothyroid 
pups had increased amount of  glycosaminoglycans. A previous study showed that 
the hypothyroid state was characterized with increased amount of  heparan sulfate 
in growth plates of  early infantile mice [31]. It was also suggested that TH regulates 
the synthesis of  aggrecanase-2, an enzyme involved in proteoglycan degradation, and 
expressed by hypertrophic chondrocytes [32]. Thus, it could be hypothesized that the 
steady state TH/TSH limits the synthesis and/or degradation of  glycosaminoglycans. 
Apparently, subclinical and overt hypothyroidism disrupt the fi ne regulation of  
ECM synthesis leading to decrease in type 2 collagen and increase in the amount of  
glycosaminoglycans.
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The major chondrocyte morphological change in both forms of  hypothyroidism 
was a decrease in the terminal hypertrophic chondrocyte height, i.e. their volume, 
suggesting the alteration in their terminal differentiation. It has been shown that 
IGF-1 mediates signals leading to maximal chondrocyte hypertrophy increasing 
proportionately the dry mass and fl uid volume in an already swelled pre-hypertrophic 
stage of  differentiation [33,34]. Thus, it is possible that in the steady-state TH/TSH 
act in combination with IGF-1 to optimise the process of  chondrocytes hyperthrophy. 
Also, large amounts of  glycosaminoglycans in ECM could be seen as a compensatory 
mechanism needed for water retention and at least partially compensating the lack of  
chondrocyte hypertrophy. It is also possible to hypothesize that the large amount of  
glycosaminoglycans with their strong water-binding capacity is not favorable for the 
infl ux of  water into the chondrocytes. 
Alteration in terminal differentiation of  chondrocytes was related to decreased 
expression of  type 10 collagen mRNA and to decreased secretion of  this protein. 
However, in the overt form of  hypothyroidism there was a visible increase in ECM 
between chondrocytes in HZ possibly refl ecting high amount of  glycosaminoglycans. 
It is well-known that TH are important for type 10 collagen synthesis and fi nal 
differentiation of  the growth plate chondrocytes to hypertrophic ones [35]. 
Independently, TSH has the same effect [30]. It is also known that an adequate 
amount of  type 10 collagen is important for cartilage calcifi cation [36]. Thus, we can 
conclude that in both forms of  hypothyroidism, TH/TSH inhibit the differentiation 
of  chondrocytes in the growth plate and that in the overt form there is a substantial 
accumulation of  ECM that does not contain the proper amount of  type 10 collagen 
and possibly is not adequately calcifi ed.
Down-regulation of  mRNA for TRAP as well as the lysosomes TRAP activity was 
infl uenced by the severity of  hypothyroidism. With methods used, it was not possible 
to assess the number of  osteoclasts, so the unresolved questions are if  TH/TSH are 
important for osteoclastogenesis or for TRAP mRNA transcription. Several studies 
demonstrated that hyperthyroidism is characterized with an increased number of  
osteoclasts followed with osteoporosis [37]. It could be presumed that there is an 
inverse effect on osteoclastogenesis in hypothyroidism. Thus, our fi ndings could point 
that alteration in TH/TSH during hypothyroidism disrupt normal osteoclast function 
during endochondral ossifi cation.
This study showed that in overt hypothyroid pups the osteoblasts in OZ retained 
a spindle shaped morphology indicating their immaturity. Also, the number of  
mature osteoblasts expressing mRNA for DMP-1 was decreased in both groups of  
hypothyroid pups, in a severity dependent manner. ECM surrounding the osteoblasts 
contained less type 1 collagen. These fi ndings are associated with a decrease in osteoid 
and high increase in calcifi ed cartilage volume that was also refl ected in an increased 
whole trabecular volume measured in this study. Previously, using micro-computed 
tomography, it was shown that ovine foetuses have an increase in the bone trabecular 
volume when subjected to intrauterine thyroidectomy [38]. So, the fi ndings of  this study 
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demonstrated that trabecular volume increases due to increased amount of  calcifi ed 
cartilage volume, which could be the consequence of  decreased osteoclast number/
activity. It was already hypothesized that bone length reduction in newborn mice could 
be a result of  compromised calcifi ed cartilage removal due to reduced expression of  
TRAP [39]. It could be assumed that mineralization of  newly formed bone tissue 
was also altered as mRNA for DMP-1 was decreased. The described changes suggest 
that inadequate functioning of  osteoclasts and immaturity of  osteoblasts during the 
subclinical and overt form of  hypothyroidism disturb the formation of  the normal 
ossifi cation zone.
CONCLUSION 
The subclinical form of  maternal hypothyroidism had a negative infl uence on the 
differentiation of  hypertrophic chondrocytes and removal of  calcifi ed cartilage by 
osteoclast in 7-day-old pups. In addition, the overt form of  maternal hypothyroidism 
had a negative infl uence on the proliferation of   chondrocytes and osteoblast function 
related to the deposition of  osteoid. The changes in growth plate infl uenced the tibia 
length in both forms of  hypothyroidism.
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UTICAJ SUBKLINIČKE I KLINIČKE FORME 
HIPOTIREOIDIZMA MAJKI PACOVA NA ENDOHONDRALNO 
FORMIRANJE KOSTIJU MLADUNACA
MILOŠEVIĆ Ivan, RADOVANOVIĆ Anita, DANILOVIĆ LUKOVIĆ Jelena, 
LUŽAJIĆ BOŽINOVSKI Tijana, SOURICE-PETIT Sophie, 
BECK-CORMIER Sarah, GUICHEUX Jerome, VEJNOVIĆ Branislav, 
KOVAČEVIČ FILIPOVIĆ Milica
Dobro je poznato da klinički hipotireoidizam majki utiče na razvoj skeleta njihovih po-
tomaka, međutim, ne postoji dovoljno podataka o uticaju supkliničke forme koja je sve 
učestalija u toku graviditeta. Pretpostavili smo da supklinička forma hipotireoidizma 
ženki pacova utiče na proces endohondralnog okoštavanja tako što remeti proliferaciju 
i diferencijaciju hondrocita, osteoklasta i osteoblasta kod mladunaca. U eksperimentu 
su korišćeni mladunci muškog pola (n=18) potomci majki iz kontrolne grupe i dve tre-
tirane grupe koje su tokom graviditeta i laktacije dobijale nisku (1.5 mg/L), ili visoku 
dozu (150 mg/L) propiltiouracila u vodi za piće. Promene na proksimalnoj epifi znoj 
ploči tibije mladunaca su određene uz pomoć morfometrije, in situ hibridizacije, imu-
nohistohemije i histohemije. Osim skraćenja tibije, zabeležena je smanjena sekrecija 
kolagena tipa 2 i 10, kao i povećana količina glikozaminoglikana u supkliničkom i 
kliničkom hipotireoidizmu u odnosu na kontrolnu grupu. Smanjena ekspresija iRNK 
za tartarat rezistentnu kiselu fosfatazu ukazuje na promene u funkciji osteoklasta, dok 
smanjena ekspresija iRNK za kiseli protein matriksa dentina–1 i smanjena sinteza ko-
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lagena tipa 1 ukazuje na poremećaj u formiranju kosti kod klinički ispoljene forme 
hipotireoidizma. Supklinički hipotireoidizam majki negativno utiče na diferencijaciju 
hipertrofi čnih hondrocita i resorpciju kalcifi kovane hrskavice kod mladunaca starih 7 
dana. Zaključak je da klinički hipotireoidizam majki ima negativan uticaj na prolifer-
aciju hondrocita i depoziciju osteoida. Smanjena dužina tibije, kod obe forme hipotir-
eoidizma, posledica je promena nastalih u toku formiranja epifi zne ploče.
